Global disparities in access to hepatitis C medicines before and during the early phase of the COVID-19 pandemic: an ARIMA-based interrupted time series analysis
- DOI
- 10.1136/bmjph-2024-001340
- Published
- 2025-01
- Container
- BMJ Public Health
- Publisher
- BMJ
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1136/bmjph-2024-001340,
title = {Global disparities in access to hepatitis C medicines before and during the early phase of the COVID-19 pandemic: an ARIMA-based interrupted time series analysis},
author = {Marie Paul Nisingizwe and Mina Tadrous and Naveed Z Janjua and Nick Bansback and Bethany Hedt-Gauthier and Katie J Suda and Michael R Law},
year = {2025},
journal = {BMJ Public Health},
doi = {10.1136/bmjph-2024-001340},
url = {https://doi.org/10.1136/bmjph-2024-001340}
}RIS
TY - JOUR TI - Global disparities in access to hepatitis C medicines before and during the early phase of the COVID-19 pandemic: an ARIMA-based interrupted time series analysis AU - Marie Paul Nisingizwe AU - Mina Tadrous AU - Naveed Z Janjua AU - Nick Bansback AU - Bethany Hedt-Gauthier AU - Katie J Suda AU - Michael R Law PY - 2025 JO - BMJ Public Health DO - 10.1136/bmjph-2024-001340 UR - https://doi.org/10.1136/bmjph-2024-001340 ER -
APA
Nisingizwe, M. P., Tadrous, M., Janjua, N. Z., Bansback, N., Hedt-Gauthier, B., Suda, K. J., & Law, M. R. (2025). Global disparities in access to hepatitis C medicines before and during the early phase of the COVID-19 pandemic: an ARIMA-based interrupted time series analysis. BMJ Public Health. https://doi.org/10.1136/bmjph-2024-001340
Source records
- crossref · retrieved 2026-09-26T01:43:30.282Z